ArticleEuropean urology2018

Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study.

James T Kearns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.